Denna sida på svenska
Loading profile information...


  • PhD in Psychiatric Epidemiology, Karolinska Institutet, 2013
  • MSc in Biomedicine, Karolinska Institutet, 2009
  • BSc in Life Science, Fudan University, 2007

Research description

My main research interest is in the field of pharmacoepidemiology. My current projects include studies of the risks and benefits of psychotropic medications (e.g., antidepressants, ADHD medication) using large-scale population data (e.g., national health registers, medical claim database).

As a separate research interest, I've also participated in a series of studies on the associations between mental and somatic disorders, using various data sources from Sweden, China, and the US.

Selected publications:

Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release.
Chang Z, Lichtenstein P, Långström N, Larsson H, Fazel S
JAMA 2016 Nov;316(17):1798-1807

Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
Chang Z, D'Onofrio B, Quinn P, Lichtenstein P, Larsson H
Biol. Psychiatry 2016 Dec;80(12):916-922

Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study.
Chang Z, Lichtenstein P, Larsson H, Fazel S
Lancet Psychiatry 2015 May;2(5):422-430

Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study.
Chang Z, Lichtenstein P, D'Onofrio B, Sjölander A, Larsson H
JAMA Psychiatry 2014 Mar;71(3):319-25

Developmental twin study of attention problems: high heritabilities throughout development.
Chang Z, Lichtenstein P, Asherson P, Larsson H
JAMA Psychiatry 2013 Mar;70(3):311-8


Loading publication list...